Notice of Meetings, 20279-20280 [2020-07561]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 70 / Friday, April 10, 2020 / Notices
development, manufacture, sale, and
distribution of upper and lower-limb
¨ ssur Hf. markets
prosthetic devices. O
and sells its prosthetics throughout the
United States through its subsidiary,
¨ ssur Americas Holdings, Inc., which is
O
headquartered in Foothill Ranch,
California. College Park, headquartered
in Warren, Michigan, also is engaged in
the development, manufacture, sale, and
distribution of upper and lower-limb
prosthetics.
The Relevant Product Market and
Market Structure
The relevant product market in which
to assess the competitive effects of the
proposed acquisition is no broader than
the development, manufacturing,
marketing, distribution, and sale of
myoelectric elbows. Myoelectric, or
powered, elbows use electromyographic
signals and battery-powered motors to
control movement of the prosthetic.
Myoelectric elbows fit directly on the
residual limb and use electrical signals
generated by muscles to move the
motorized elbow componentry.
Myoelectric elbows provide substantial
functional advantages over mechanical
elbows, such as being easier and more
natural to control than mechanical
elbows.
The relevant geographic area in which
to assess the competitive effects of the
Acquisition is the United States. The
United States has unique regulatory and
reimbursement requirements that
distinguish it from other countries
where myoelectric elbows are sold, and
manufacturers require U.S. sales and
clinical personnel to support their U.S.
clinic customers.
The U.S. market for myoelectric
elbows is highly concentrated.
Respondent College Park is a leading
supplier of myoelectric elbows and
¨ ssur is currently
Respondent O
developing its own myoelectric elbow.
The only other participants in the U.S.
myoelectric elbow market are Otto Bock
Healthcare North America and Fillauer
LLC.
lotter on DSKBCFDHB2PROD with NOTICES
Effects of the Acqusition
Absent a divestiture, the Acquisition
is likely to harm customers of
myoelectric elbows in the United States.
College Park is currently a leading
manufacturer of myoelectric elbows in
¨ ssur is the largest
the United States. O
prosthetic manufacturer in the United
States that does not currently offer a
myoelectric elbow, but it is developing
a myoelectric elbow to enter the market.
Absent the Acquisition, the highly
concentrated myoelectric elbow market
likely would benefit significantly from
VerDate Sep<11>2014
18:00 Apr 09, 2020
Jkt 250001
¨ ssur’s entry and O
¨ ssur would compete
O
directly for College Park’s customers.
Entry
Entry into the myoelectric elbow
market would not be timely, likely, or
sufficient in magnitude, character, and
scope to deter or counteract the
anticompetitive effects of the proposed
Acquisition. De novo entry is unlikely to
occur in a timely manner because the
time required for product development
and market adoption is lengthy, and the
only passive and body-powered elbow
manufacturers already sell myoelectric
elbows.
The Consent Agreement
The proposed Order would remedy
the competitive concerns raised by the
¨ ssur
proposed transaction by requiring O
to divest to Steeper the worldwide
College Park myoelectric elbow
business. The divestiture package
consists of the following assets and
rights: all assets and rights to research,
develop, manufacture, market, and sell
the College Park myoelectric elbow
products, including all related
intellectual property and other
confidential business information,
manufacturing technology, and existing
inventory. Steeper will also be hiring
several key College Park employees who
are essential to the divested business.
Additionally, the Order requires that, at
¨ ssur must
the request of Steeper, O
provide transitional assistance for up to
fifteen months following the divestiture
date (with an option to extend further
with Commission approval). These
services include logistical,
administrative, and sales and marketing
support. The Order also includes other
standard terms designed to ensure the
viability of the divested business. The
provisions of the proposed Consent
Agreement position Steeper to become
an effective competitor in the market for
myoelectric elbows in the United States.
Under the Order, College Park is
required to divest its myoelectric elbow
business no later than ten days from the
¨ ssur. If the
close of its acquisition by O
Commission determines that Steeper is
not an acceptable acquirer, or that the
manner of the divestiture is not
acceptable, the Order requires College
Park to either unwind the sale of rights
and assets to Steeper and then divest the
assets to a Commission-approved
acquirer within 180 days of the date the
Order becomes final, or modify the
divestiture to Steeper in the manner the
Commission determines is necessary to
satisfy the requirements of the Order.
The Order also requires a monitor to
¨ ssur’s compliance with the
oversee O
obligations set forth in the Order. If
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
20279
¨ ssur does not fully comply with the
O
divestiture and other requirements of
the Order, the Commission may appoint
a Divestiture Trustee to divest the
myoelectric elbow assets and perform
¨ ssur’s other obligations consistent
O
with the Order. The Order also requires
¨ ssur shall not acquire, without
that O
providing advance written notification
to the Commission, any myoelectric
prosthetic elbow manufacturer or
product for a period of five years from
the date the Order is issued.
The purpose of this analysis is to
facilitate public comment on the
Consent Agreement to aid the
Commission in determining whether it
should make the Consent Agreement
final. This analysis is not an official
interpretation of the proposed Consent
Agreement and does not modify its
terms in any way.
By direction of the Commission.
April J. Tabor,
Acting Secretary.
[FR Doc. 2020–07588 Filed 4–9–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of five AHRQ
subcommittee meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will be closed to the public.
DATES: See below for dates of meetings:
1. Health Care Research and Training
(HCRT)
Date: May 20–22, 2020
2. Health System and Value Research
(HSVR)
Date: June 2–3, 2020
3. Healthcare Information Technology
Research (HITR)
Date: June 3–5, 2020
4. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: June 10–11, 2020
5. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: June 9–11, 2020
ADDRESSES: Agency for Healthcare
Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland
20857.
SUMMARY:
E:\FR\FM\10APN1.SGM
10APN1
20280
Federal Register / Vol. 85, No. 70 / Friday, April 10, 2020 / Notices
(To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Jenny Griffith, Acting Committee
Management Officer, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427–
1557.
SUPPLEMENTARY INFORMATION: In
accordance with section 10 (a)(2) of the
Federal Advisory Committee Act (5
U.S.C. App. 2), AHRQ announces
meetings of the above-listed scientific
peer review groups, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committee. The subcommittee meetings
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2 section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
FOR FURTHER INFORMATION CONTACT:
Virginia L. Mackay-Smith,
Associate Director, AHRQ.
[FR Doc. 2020–07561 Filed 4–9–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; National Advisory Committee
on the Sex Trafficking of Children and
Youth in the United States (NAC)
Recommendations and State SelfAssessment Survey (NEW)
Office on Trafficking in
Persons; Administration for Children
and Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Office on Trafficking in
Persons (OTIP), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to collect
data for a new survey, the National
Advisory Committee on the Sex
Trafficking of Children and Youth in the
United States (NAC) Recommendations
and State Self-Assessment Survey.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
SUMMARY:
Administration for Children and
Families, Office of Planning, Research
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The Preventing Sex
Trafficking and Strengthening Families
Act of 2014 mandated the NAC to
develop a report describing how each
state has implemented its
recommendations to address sex
trafficking in children and youth. The
NAC proposes to administer a survey
allowing states to assess their progress
in implementing NAC
recommendations. Submissions will
allow states to document their efforts in
the following sections:
Multidisciplinary Response, Screening
and Identification, Child Welfare,
Service Provision, Housing, Law
Enforcement and Prosecution, Judiciary,
Demand Reduction, Prevention,
Legislation and Regulation, Research
and Data, and Funding. Each state will
have the opportunity to provide a selfassessed tier ranking for each
recommendation, a justification of their
assessment, sources for their
assessment, and the public or private
nature of those sources.
Respondents: State Governors, Child
Welfare Agencies, Local Law
Enforcement, and Other Local Agencies.
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of respondents
contributing for
50 States
Total number
of responses
per
respondent
Average
burden hours
per response
for individuals
in States
Average
burden hours
per State
response
Total burden
hours per
individual
Annual burden
hours
250
1
6.85
34.25
1,713
571
lotter on DSKBCFDHB2PROD with NOTICES
NAC Recommendations and State SelfAssessment Survey ..............................
Estimated Total Annual Burden
Hours: 571.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
VerDate Sep<11>2014
18:00 Apr 09, 2020
Jkt 250001
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 1314b.
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of supplemental awards.
AGENCY:
[FR Doc. 2020–07554 Filed 4–9–20; 8:45 am]
PO 00000
Health Resources and Services
Administration
Health Center Program
Mary B. Jones,
ACF/OPRE Certifying Officer.
BILLING CODE 4184–47–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HRSA provided supplemental
funding to existing State and Regional
Primary Care Association Cooperative
Agreements (PCAs) to support enhanced
SUMMARY:
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\10APN1.SGM
10APN1
]]>Agencies
[Federal Register Volume 85, Number 70 (Friday, April 10, 2020)]
[Notices]
[Pages 20279-20280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07561]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meetings
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of five AHRQ subcommittee meetings.
-----------------------------------------------------------------------
SUMMARY: The subcommittees listed below are part of AHRQ's Health
Services Research Initial Review Group Committee. Grant applications
are to be reviewed and discussed at these meetings. Each subcommittee
meeting will be closed to the public.
DATES: See below for dates of meetings:
1. Health Care Research and Training (HCRT)
Date: May 20-22, 2020
2. Health System and Value Research (HSVR)
Date: June 2-3, 2020
3. Healthcare Information Technology Research (HITR)
Date: June 3-5, 2020
4. Healthcare Effectiveness and Outcomes Research (HEOR)
Date: June 10-11, 2020
5. Healthcare Safety and Quality Improvement Research (HSQR)
Date: June 9-11, 2020
ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland 20857.
[[Page 20280]]
FOR FURTHER INFORMATION CONTACT: (To obtain a roster of members, agenda
or minutes of the non-confidential portions of the meetings.)
Jenny Griffith, Acting Committee Management Officer, Office of
Extramural Research Education and Priority Populations, Agency for
Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427-1557.
SUPPLEMENTARY INFORMATION: In accordance with section 10 (a)(2) of the
Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces
meetings of the above-listed scientific peer review groups, which are
subcommittees of AHRQ's Health Services Research Initial Review Group
Committee. The subcommittee meetings will be closed to the public in
accordance with the provisions set forth in 5 U.S.C. App. 2 section
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Agenda items for these meetings are subject to change as priorities
dictate.
Virginia L. Mackay-Smith,
Associate Director, AHRQ.
[FR Doc. 2020-07561 Filed 4-9-20; 8:45 am]
BILLING CODE 4160-90-P
